EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Fracture risk revisited: Bone mineral density T‐score and fracture risk in type 2 diabetes

V Van Hulten iD, J H M Driessen, S Andersen, A Kvist, R Viggers, D Bliuc, J R Center, M C J G Brouwers, P Vestergaard, J P van den Bergh

Diabetes, Obesity and Metabolism · 2024-11 · 26 (11) · 5325-5335

DOI: 10.1111/dom.15890 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 04.09.2024. Verfasst von V Van Hulten und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Bone Density, Osteoporotic Fractures, Absorptiometry, Photon. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stichting de Drie Lichten, Novo Nordisk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To study the association between femoral neck (FN) bone mineral density (BMD) T‐score and fracture risk in individuals with and without type 2 diabetes (T2D). Materials and Methods We performed a single‐centre retrospective cohort study using the Danish National Health Service. BMD of the FN was measured by dual‐energy X‐ray absorptiometry. Cox proportional hazards regression models were used to study the association between FN BMD T‐score and fractures in individuals with and without T2D separately, adjusted for age, comorbidities and comedication. The results from this analysis were used to estimate the 10‐year absolute fracture risk.

Results

In total, there were 35,129 women (2362 with T2D) and 7069 men (758 with T2D). The FN BMD T‐score was significantly associated with risk of any, hip and major osteoporotic fracture in men and women with [adjusted hazard risk ratios (aHR) women, hip: 1.57; 95% confidence interval (CI) 1.24–2.00, incidence rate (IR) 8.7; aHR men, hip: 1.55; 95% CI 1.01–2.36, IR 4.6] and without T2D (aHR women, hip: 1.75; 95% CI 1.64–1.87, IR 7.0; aHR men, hip: 1.97, 95% CI 1.73–2.25, IR 6.3), and its ability to predict fracture risk was similar. Fracture IRs were not significantly different for individuals with or without T2D, nor was the estimated cumulative 10‐year fracture risk.

Conclusions

The FN BMD T‐score was significantly associated with hip, non‐spine and major osteoporotic fracture risk in men and women with and without T2D. Fracture risk for a given T‐score and age was equal in individuals with and without T2D, as was the ability of the FN BMD T‐score to predict fracture risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Bone DensityOsteoporotic FracturesAbsorptiometry, PhotonFemur NeckHumansMaleFemaleMiddle AgedRetrospective StudiesAgedRisk FactorsDenmarkOsteoporosisProportional Hazards ModelsIncidence

Stichwörter der Autor:innen

cohort studydiabetes complicationsinsulin therapytype 2 diabetes

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands.
  • School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands.
  • Department of Clinical Pharmacy, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
  • Steno Diabetes Center North Denmark, Aalborg, Denmark.
  • Department of Endocrinology and Metabolism, Molecular Endocrinology & Stem Cell Research Unit (KMEB), Odense University Hospital, Odense, Denmark.
  • Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.

ORCID-Profile: V Van Hulten

Förderung

  • Stichting de Drie Lichten
  • Novo Nordisk

Zitieren

APA

Van Hulten, V., Driessen, J. H. M., Andersen, S., Kvist, A., Viggers, R., Bliuc, D., Center, J. R., Brouwers, M. C. J. G., Vestergaard, P., & van den Bergh, J. P. (2024). Fracture risk revisited: Bone mineral density T‐score and fracture risk in type 2 diabetes. Diabetes, Obesity and Metabolism, 26(11), 5325-5335. https://doi.org/10.1111/dom.15890

Vancouver

Van Hulten V, Driessen JHM, Andersen S, Kvist A, Viggers R, Bliuc D, et al. Fracture risk revisited: Bone mineral density T‐score and fracture risk in type 2 diabetes. Diabetes, Obesity and Metabolism. 2024;26(11):5325-5335. doi:10.1111/dom.15890

BibTeX
@article{VanHulten2024,
  author = {Van Hulten, V and Driessen, J H M and Andersen, S and Kvist, A and Viggers, R and Bliuc, D and Center, J R and Brouwers, M C J G and Vestergaard, P and van den Bergh, J P},
  title = {Fracture risk revisited: Bone mineral density T‐score and fracture risk in type 2 diabetes},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  volume = {26},
  number = {11},
  pages = {5325--5335},
  doi = {10.1111/dom.15890}
}
Kostenlos starten →